Int J Biol Sci 2012; 8(7):1051-1052. doi:10.7150/ijbs.3665
Spontaneous Transformation of Stem Cells In Vitro and the Issue of Cross-Contamination
1. Department of Biomedicine, University of Bergen, Jonas Lies vei 91, N-5020 Bergen, Norway
2. NorLux Neuro-Oncology Laboratory, Oncology Department, Centre de Recherche Public de la Santé (CRP-Santé), Luxembourg
Torsvik A, Røsland GV, Bjerkvig R. Spontaneous Transformation of Stem Cells In Vitro and the Issue of Cross-Contamination. Int J Biol Sci 2012; 8(7):1051-1052. doi:10.7150/ijbs.3665. Available from http://www.ijbs.com/v08p1051.htm
We have read with interest the paper “Long-term cultured human neural stem cells undergo spontaneous transformation to tumor-initiating cells”, recently published by Wu et al. . In this study the authors show spontaneous transformation of human fetal striatum neural stem cells (hsNSCs) in culture, and that the transformed cells (T1) are characterized by stem cell-like features, the expression of neural stem cell markers, abnormal karyotype and an increased growth rate. In the text they refer to previous reports on spontaneous MSC transformation [2, 3]. However, they fail to inform the readers that both these publications have later been retracted or corrected since both research groups detected that their transformed cells were cross-contaminated with cancer cells [4, 5]. In the article by Wu and colleagues, they have characterized the T1 cells by DNA fingerprinting. Most interesting, the DNA fingerprint of the transformed cells (T1) did not match the “cell of origin”, and the authors explain this by genetic instability. However, we have compared the T1 fingerprint published by Wu et al., with public available cell line STR profiles, and find that the T1 STR profile published by Wu et al. is surprisingly similar to HeLa cells, Table 1. The DNA fingerprinting profile of cancer cells compared to normal cells is characterized by large differences in peak height at one or more loci, indicating genetic instability, occasional additional alleles at a locus, indicating gene duplication events, and loss of heterozygosity (LOH), at one or more loci [6, 7]. Genetic imbalance will in other words not generate a completely new fingerprinting profile.
STR profiling is currently the recommended test for cell line authentication due to its high power of discrimination and the possibility to compare the numerical code obtained from various laboratories . Wu and colleagues analyzed their cells by using the PowerPlex 16 System Kit from Promega. The kit provides 15 STR markers as well as the gender determinator Amelogenin, and it has a matching probability of > 1 in 1.83×10e17 (www.promega.com). The same kit was recently used to determine the STR profile of HeLa cells , showing 97% identity between T1 and HeLa with only one LOH (Table 1). According to general recommendations, the profile of identical or closely related profiles should match at 80% or more of the alleles , and profiles with an identity level between 50 and 75% must be regarded with suspicion . The HeLa profiles listed in Table 1 match T1 with 80-97% accuracy. A minor variation is seen at one locus when comparing the STR profile reported by ATCC and CLS (D13S317: 12,13.3 and 13,13.3) and Wu (D13S317: 12,14). According to the Promega Protocol for PowerPlex16, each allele at the D13S317 locus separates by 4 nucleotides, and it is therefore unclear if the allele at D13S317 13.3 is correct. There is at present several batches of HeLa cells available, and minor differences exists between them .
A number of scientists have pointed at the problem of cross-contamination for decades, and it is now highly recommended to authenticate cells by DNA fingerprinting [7, 9]. Several databases for checking the fingerprinted profiles are available, such as STR profile databases at ATCC (www.lgcstandards-atcc.org) and DSMZ (www2.dsmz.de). Also a list of 360 cross-contaminated cell lines is available to help researchers quality-check their work , and HeLa is still the most frequent cross-contaminating cell line . In conclusion, it is highly questionable if the article presented by Wu et al., actually describes a transforming event of hsNSCs.
STR fingerprinting profile of hsNSC, T1 and HeLa
|Cell line||D5S818||D13S317||D7S820||D16S539||CSF1PO||PentaD||D3S1358||THO1||D21S11||D18S51||Penta E||Amel.||vWA||D8S1179||TPOX||FGA||Ref.|
1. Wu W, He Q, Li X. et al. Long-term cultured human neural stem cells undergo spontaneous transformation to tumor-initiating cells. Int J Biol Sci. 2011;7:892-901
2. Rosland G.V, Svendsen A, Torsvik A. et al. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res. 2009;69:5331-5339
3. Rubio D, Garcia-Castro J, Martin M.C. et al. Spontaneous human adult stem cell transformation. Cancer Res. 2005;65:3035-3039
4. Fuente Rdela, Bernad A, Garcia-Castro J. et al. Retraction: Spontaneous human adult stem cell transformation. Cancer Res. 2010;70:6682
5. Torsvik A, Rosland G.V, Svendsen A. et al. Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track - letter. Cancer Res. 2010;70:6393-6396
6. Masters J.R, Thomson J.A, Daly-Burns B. et al. Short tandem repeat profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci U S A. 2001;98:8012-8017
7. A.T.C.C.S.D.O.W.ASN-0002. Cell line misidentification: the beginning of the end. Nat Rev Cancer. 2010;10:441-448
8. Jiang L, Zeng X, Wang Z. et al. Oral cancer overexpressed 1 (ORAOV1) regulates cell cycle and apoptosis in cervical cancer HeLa cells. Mol Cancer. 2010;9:20
9. Barallon R, Bauer S.R, Butler J. et al. Recommendation of short tandem repeat profiling for authenticating human cell lines, stem cells, and tissues. In Vitro Cell Dev Biol Anim. 2010;46:727-732
10. Capes-Davis A, Theodosopoulos G, Atkin I. et al. Check your cultures! A list of cross-contaminated or misidentified cell lines. Int J Cancer. 2010;127:1-8
Corresponding author: Anja Torsvik, Department of biomedicine, University of Bergen, Jonas Lies vei 91, N-5020 Bergen, Norway, anja.torsvikuib.no. Tel: +47-55 58 61 28, Fax: +47-55 58 63 60